Making Sense of Novartis and GlaxoSmithKline's Web of Deals - Presented by: The Aol. On Network

The pharmaceutical industry had a deluge of M&A activity on Tuesday as heavyweights Novartis and GlaxoSmithKline announced they were trading $20 billion worth of assets. Novartis will purchase GSK's oncology portfolio for $14.5 billion, strengthening its number two spot in the specialty. Meanwhile, GSK will purchase Novartis' vaccines unit for $5.25 billion. The two companies will also form a separate consumer healthcare business in which GSK will hold a 63.5 percent majority stake.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.75 0.02 ▲ 0.12%
AAPL $ 132.54 1.15 ▲ 0.88%
ONTY $ 3.01 0.50 ▲ 19.92%
HPQ $ 34.76 0.93 ▲ 2.75%
PBR $ 9.15 0.34 ▼ 3.58%
T $ 34.71 0.36 ▼ 1.03%
MSFT $ 46.90 0.52 ▼ 1.10%
F $ 15.27 0.24 ▼ 1.55%

As of 5/22/2015, 04:15 PM

Latest News Headlines

View All Latest Headlines